37C heated chamber using hydraulic pressure to squeeze a polymer left ventricle. Utilizes a tissue aortic valve, mechanical mitral valve, compliance chambers and programmable flow profile.
Opsin Biotherapeutics Inc, Opsin Bio for short, is a joint venture between DesignPlex Biomedical and Nanoscope Technologies. The goal of Opsin Bio is to bring new and innovative optogenetic neuromodulation treatments for chronic pain to help bring an end to the opioid epidemic.
An opsin is a protein that is activated by the action of light. Opsin Bio uses a revolutionary new method to mitigate pain. By using a Multi Characteristic Opsin (MCO) and targeting a specific area of the brain, we hypothesize that we can "turn off" pain at the source.
Evaheart Inc. has developed a unique blood pump for long term left ventricular support.
This is a fully functional prototype consisting of a touch screen graphic display, 3-phase sensorless motor drive, 2-wire motor driver, closed loop control with 2 pressure sensors, membrane keypad, and rechargeable li-ion battery pack. The case is 3-D printed with an industrial coating so it looks and functions like a finished product.
The Vital Ventilator was developed by NASA's Jet Propulsion Laboratory in just 37 days and received an emergency Use Authorization by the FDA to combat the growing need for ventilation due to COVID-19.
DesignPlex Biomedical was selected as one of only 8 United States manufacturers to receive full licensing rights to the new Ventilator. We are now implementing additional design features and plan to take the device through full regulatory approval for COVID-19, future pandemics, and expanded indications.